Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Boston Life Sciences demonstrates efficacy of antiangiogenic factor

Jan. 24, 1997

Brain cancer gene identified

Jan. 24, 1997

Novel cytotoxic protein derived from bacterial source

Jan. 24, 1997

Cell adhesion inhibitors claimed by Nippon Shinyaku

Jan. 23, 1997

Development partners sought for novel antimitotic agents

Jan. 22, 1997

NYU seeks partners for development of potential anticancer/antiinflammatory therapies

Jan. 22, 1997

Collaborators sought for development of combination chemotherapy approach

Jan. 22, 1997

CRADA offered for new metastasis gene therapy

Jan. 22, 1997

MDI offers potential anticancer agent for licensing

Jan. 22, 1997

Research suggests potential of anti-DNA MeTase antisense compounds

Jan. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...